Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Industry News

Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions

October 08, 2015

News Industry News

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

September 04, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Industry News

UH Case Medical Center first in Ohio to implant new ventricular assist device

June 04, 2015

News Industry News

Abiomed Impella 2.5 Receives FDA Approval for Elective and Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures

March 23, 2015

News Industry News

Clinical Trial Results for Impella RP Right Ventricular Heart Failure Trial, RECOVER RIGHT, Released at TCT 2014

September 16, 2014

News Industry News

Abiomed Surpasses 20,000 Impella Patients in the United States

June 03, 2014

News Industry News

Abiomed Receives Continuous Access Protocol (CAP) for RECOVER RIGHT Impella RP Study

May 21, 2014

News Industry News

Abiomed's Impella(R) Technology Showcased at EuroPCR 2014

May 19, 2014

News Industry News

Abiomed Receives Reimbursement Approval for Impella in The Netherlands

May 28, 2013

News Industry News

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

November 08, 2011

News Industry News

Economic Study Demonstrates Cost-Effectiveness of Impella Presented at TCT 2011

November 07, 2011

Advertisement

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

UH Case Medical Center first in Ohio to implant new ventricular assist device

Abiomed Impella 2.5 Receives FDA Approval for Elective and Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures

Clinical Trial Results for Impella RP Right Ventricular Heart Failure Trial, RECOVER RIGHT, Released at TCT 2014

Abiomed Surpasses 20,000 Impella Patients in the United States

Abiomed Receives Continuous Access Protocol (CAP) for RECOVER RIGHT Impella RP Study

Abiomed's Impella(R) Technology Showcased at EuroPCR 2014

Abiomed Receives Reimbursement Approval for Impella in The Netherlands

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

Economic Study Demonstrates Cost-Effectiveness of Impella Presented at TCT 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content